Skip to content

Mobile Smoking Treatment for Hispanic Individuals Who Smoke

Culturally-Adapted Smoking Cessation Mobile App for Hispanic Individuals Who Smoke

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06586034
Enrollment
56
Registered
2024-09-19
Start date
2025-04-30
Completion date
2026-03-31
Last updated
2024-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking Cessation

Keywords

Mobile App, Smoking Cessation, Hispanic/Latino

Brief summary

The specific aims of the project are to develop and test a mobile application for smoking cessation for Hispanic individuals who smoke called Impacto.

Detailed description

A total of 56 Hispanic individuals who smoke will be recruited for this project. Six (6) participants will complete usability/functionality testing of Impacto 2.0 in the English language for both iOS and Android. Following usability/functionality testing, a field test with 50 adult Hispanic individuals who smoke (50% English-speaking and 50% Spanish-speaking) will be recruited nationally and will receive Impacto 2.0 (50% Android and iOS platforms).

Interventions

This is the mobile app to be developed and evaluated in this project. It is designed for both English and Spanish languages and is culturally tailored for Hispanic/Latino/Latinx individuals who smoke. Impacto will be developed for both iOS and Android platforms. The mobile app aims to aid smoking cessation by targeting elevated anxiety sensitivity.

Sponsors

University of Houston
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 1\) being Hispanic, 2) at least 18 years of age, 2) currently smoking (i.e., at least 5 cigarettes/day) biochemically verified by a CO > 7, 3), meeting criteria for high AS (cut-off score of 5 on the Short Scale Anxiety Sensitivity Index), 4) motivation to quit > 5 on a 10 pt. scale, 5) able to provide informed consent, 6) has daily access to their own iPhone or Android smartphone, and 7) is a fluent English or Spanish speaker.

Exclusion criteria

* 1\) current participation in substance abuse treatment, 2) in psychotherapy for anxiety or depression, 3) concurrent use of medication for anxiety or depression, 4) active suicidality (ideation, intent, and/or plan), or 5) current psychosis.

Design outcomes

Primary

MeasureTime frameDescription
7-Day Point Prevalence Smoking AbstinenceEnd of treatment (Week 8)7-day point prevalence smoking status (verification via carbon monoxide).

Secondary

MeasureTime frameDescription
Anxiety SensitivityBaseline, week 4, and end of treatment (Week 8)Anxiety sensitivity will be assessed using the Short Scale Anxiety Sensitivity Index (SSASI).

Contacts

Primary ContactJustin M Shepherd, PhD
jmsheph4@central.uh.edu713-743-8056

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026